1 – 18 of 18
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval
2024) In QJM - Monthly Journal of the Association of Physicians(
- Contribution to journal › Letter
-
Mark
Delays in dealing with complaints against drug companies are growing, BMJ finds
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2023
-
Mark
Pharmaceutical industry payments to NHS trusts in England : A four-year analysis of the Disclosure UK database
(
- Contribution to journal › Article
-
Mark
Authors’ reply to Fell
(
- Contribution to journal › Letter
-
Mark
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
(
- Contribution to journal › Article
- 2022
-
Mark
Capitalizing on transparency: commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
(
- Contribution to journal › Article
-
Mark
Tip of the iceberg? Country- and company-level analysis of drug company payments for research and development in Europe
(
- Contribution to journal › Article
-
Mark
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
(
- Contribution to journal › Article
-
Mark
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
(
- Contribution to journal › Article
- 2021
-
Mark
Sociologisk forskning om covid-19-pandemin : En introduktion
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: A European policy review
(
- Contribution to journal › Article
- 2020
-
Mark
Pharmaceutical lobbying and pandemic stockpiling : A feeling of déjà vu in the Nordic countries and why the sociological perspective is crucial to understand COVID-19
(
- Contribution to journal › Article
- 2018
-
Mark
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
(
- Contribution to journal › Article
-
Mark
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
(
- Contribution to journal › Article
-
Mark
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
(
- Contribution to journal › Letter
- 2017
-
Mark
Two thirds of Survey Respondents in Southern Sweden used Complementary or Alternative Medicine (CAM) in 2015
(
- Contribution to journal › Article
- 2015
-
Mark
Etik och marknadsföring: Skäl till självkritik?
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process
(
- Contribution to journal › Article